KINDERHOOK, N.Y.--(BUSINESS WIRE)--American Bio Medica Corporation (NASDAQ:ABMC) has received notice from the NASDAQ OMX Group (“NASDAQ”) that NASDAQ has determined to extend its suspension of the bid price and market value of publicly held shares requirements, and that enforcement of these rules is now scheduled to resume on Monday, July 20, 2009.
